Effendy et al. / Inorganica Chimica Acta 308 (2000) 65–72
67
1
IR (Nujol, cm−1): 3124 w (CꢀH), 2429 m, 2397 m, 2379
sh (BꢀH), 1544 w, 1502 m (C···C, C···N), 355 m, 321
mbr, 279 m. Anal. Calc. for C9H10AgBN6; C, 33.8; H,
3.1; N, 26.3; Found: C, 33.4, H, 3.3; N, 26.1%. MS,
FAB: m/z 747 [M+Ag]+ (80%), 641 [M+H]+ (3%),
429 [M−HB(pz)3]+ (100%) (all peaks are at the center
of an isotopic cluster).
Et2O (1:1) (yield 98%). m.p. (dec.): 258°C. H NMR
(CDCl3, 293 K): l 6.21 (s br, 4H, 4-CH), 7.04 (s br, 4H,
5-CH), 7.42 (s br, 4H, 3-CH). H NMR (CDCl3, 193
1
K): l 5.16 (s, 2H, 4-CH), 5.30 (s, 4H, 4-CH), 7.51 (s,
6H, 5-CH), 7.68 (s, 6H, 3-CH). 13C NMR (CDCl3, 293
K): l 105.5 (s, 4-CH), 135.5 (s, 5-CH), 143.0 (s, 3-CH).
\
M
(CH2Cl2)=0.4 V−1 cm2 mol−1. IR (Nujol, cm−1):
3132 vw, 3093 vw (CꢀH), 1504 w (C···C,C···N), 368 m,
350 m, 331 w, 311 w, 261 m. Anal. Calc. for
C12H12AgBN8; C, 37.3, H; 3.1; N, 29.0; Found: C, 37.0;
H, 3.1; N, 28.9%. MS, FAB: m/z 1651 [4M+Ag]+
(30%), 1545 [4M+H]+ (25%), 1275 [3M+Ag]+ (45%),
883 [2M+Ag]+ (20%), 495 [2M−B(pz)4]+ (100%), 426
[2M+H−pzH−B(pz)4]+ (60%), 319 [M−Ag−pz−
B(pz)4]+ (90%), (all peaks are at the center of an
isotopic cluster).
2.2.3. [Ag{HB(3,5-Me2pz)3}]2 (3)
3 was prepared following the methods of [14], and as
for 2 above, by using AgNO3 (0.170 g, 1 mmol) and
K[HB(3,5-Me2pz)3] (0.336 g, 1 mmol) in methanol (50
ml) at 298 K. Compound 3 was recrystallized from
CHCl3–Et2O (1:1) (yield 90%). X-ray quality crystals of
this molecule were obtained from ethyl acetate–CHCl3
at r.t. m.p. (dec.): 200°C (lit. dec. \190° [14]). 1H NMR
(CDCl3, 293 K): l 1.92 (s, 9H, 5-CH3), 2.31 (s, 9H,
3-CH3), 5.77 (s, 3H, 4-CH). \M (CH2Cl2)=0.1 V−1
2.2.6. [Ag{B(3-Mepz)4}]n (6)
1
cm2 mol−1. H NMR of solution of crystals (CDCl3,
Compound 6 was prepared similarly to compound 2,
by using AgNO3 (0.170 g, 1 mmol) and K[B(3-Mepz)4]
(0.374 g, 1 mmol) in methanol (50 ml) at 298 K (yield
293 K): l 1.91 (s, 6H, 5-CH3), 2.24 (s, 6H, 3-CH3), 2.27
(s, 2H, 3- or 5-CH3), 2.30 (s, 2H, 3- or 5-CH3), 5.76 (s,
1
1
2H, 4-CH), 5.83 (s, 1H, 4-CH). H NMR (CDCl3, 193
97%). m.p. (dec.): 220°C. H NMR (DMSO, 293 K): l
K): l 1.87 (s, 18H, 5-CH3), 2.30 (s, 18H, 3-CH3), 5.72
(s, 6H, 4-CH). 13C NMR (CDCl3, 293 K): l 13.9 (s,
CH3), 14.8 (s, CH3), 105.3 (s, 4-CH), 146.8 (s, 5-CCH3),
150.0 (s, 3-CCH3). IR (Nujol, cm−1): 3118 vw (CꢀH),
2509 w (BꢀH), 1538 m (C···C,C···N), 553 w, 473 m, 456
s, 359 m, 349 w, 327 w, 303 w, 255 s. Anal. Calc. for
C15H22AgBN6; C, 44.6; H, 5.5; N, 20.8; Found: C, 44.2;
H, 5.6; N, 20.6%. MS, FAB: m/z 917 [M+Ag]+
(100%), 809 [M+H]+ (3%), 714 [M+H−pzH]+
(10%), 606 [M+H−pzH+Ag]+ (30%), 512 [M+
2H−2pzH+Ag]+ (10%), 403 [M−HB(3,5-Me2pz)3]+
(15%) (all peaks are at the center of an isotopic cluster).
2.08 (s br, 12H, 3-CH3), 5.92 (d, 4H, 5-CH), 6.70 (d,
4H, 3-CH). IR (Nujol, cm−1): 3126 vw, 3107 w (CꢀH),
1519 m (C···C,C···N), 423 m, 413 m, 405 s, 393 m, 253
s. Anal. Calc. for C16H20AgBN8; C, 43.5; H, 4.6; N,
25.3; Found: C, 43.4; H, 4.6; N, 25.0%. MS, FAB: m/z
993 [M+Ag]+ (10%), 912 [M+Ag+H-pzH]+ (10%),
739 [M+H+Ag−B(3-Mepz)3]+ (40%), 550 [M−B-
(3-Mepz)4]+ (50%), 468 [M+H−3-MepzH−B(3-
Mepz)4]+ (38%), 363 [M−Ag−3-Mepz−B(3-
Mepz)4]+ (100%), (all peaks are at the center of an
isotopic cluster).
2.2.7. [Ag{B(im)4}n] (7)
2.2.4. [Ag{HB(4-Brpz)3}]2 (4)
Compound 7 was prepared similarly to compound 2,
by using AgNO3 (0.170 g, 1 mmol) and Na[B(im)4]
(0.302 g, 1 mmol) in methanol (50 ml) at 298 K (yield
93%); 2 is insoluble in all common organic solvents.
m.p. (dec.): 250°C. IR (Nujol, cm−1): 3140 w, 3112 w
(CꢀH), 1559 w (C···C, C···N), 374 w, 332 w, 240 w. Anal.
Calc. for C12H12AgBN8; C, 37.3; H, 3.1; N, 29.0; Found:
C, 37.0; H, 3.2; N, 28.7%.
Compound 4 was prepared similarly to compound 2,
by using AgNO3 (0.170 g, 1 mmol) and K[HB(4-Brpz)3]
(0.480 g, 1 mmol) in methanol (50 ml) at 298 K.
Compound 4 was recrystallized from CHCl3/Et2O (1:1)
(yield 91%). m.p. (dec.): 170°C. H NMR (CDCl3, 293
K): l 6.90 (s, 6H, 3-CH), 6.60 (s, 6H, 5-CH). H NMR
(CDCl3, 193 K): l 5.18 (s, 1H), 5.30 (s, 2H), 6.83 (s, 3H,
3-CH), 6.58 (s, 3H, 5-CH), 7.51 (s, 6H), 7.53 (s, 3H),
7.68 (s, 6H). 13C NMR (CDCl3, 293 K): l 94.1 (s,
1
1
2.2.8. [(Hmimt)Ag{B(3-Mepz)4}] (8)
4-CBr), 134.7 (s, 5-CH), 142.6 (s, 3-CH).
\
To a stirred diethyl ether suspension (20 ml) of 6
(0.442 g, 1 mmol) was added Hmimt (0.114 g, 1 mmol)
at r.t. The mixture was stirred for 4 h and the solid
obtained was then filtered off, washed with diethyl
ether, and shown to be compound 8 (yield 90%). m.p.
M
(CH2Cl2)=0.8 V−1 cm2 mol−1. IR (Nujol, cm−1):
3125 vw (CꢀH), 2374 m (BꢀH), 1518 w (C···C,C···N),
419 w, 331 m, 285 w. Anal. Calc. for C9H7AgBBr3N6; C,
19.4; H, 1.3; N, 15.1; Found: C, 19.2; H, 1.2; N, 15.2%.
1
(dec.): 230°C. H NMR (CDCl3, 293 K): l 2.19 (s br,
2.2.5. [Ag{B(pz)4}]n (5)
12H, 3-CH3), 3.62 (s, 3H, N-CH3), 6.00 (d, 4H, 5-CH),
6.59 (d, 1H, 4- or 5-CH), 6.68 (d, 4- or 5-CH), 7.11 (d,
4H, 3-CH). 13C NMR (CDCl3, 293 K): l 13.9 (s,
3-CH3), 34.7 (s, N-CH3), 104.4 (s, 4-CH), 117.7 (br,
C=S), 119.8 (s, 3-CCH3), 134.8 (s, 4- or 5-CH), 136.5
Compound 5 was prepared following the method for
compound 2 and [14] by using AgNO3 (0.170 g, 1 mmol)
and K[B(pz)4] (0.318 g, 1 mmol) in methanol (50 ml) at
298 K. Compound 5 was recrystallized from CHCl3/